(Q30309287)

16 June 2017

1 reference

title

The role of leukotrienes in upper and lower airway inflammation and the implications for treatment (English)

1 reference

16 June 2017

0 references

1

Larry Borish

1 reference

16 June 2017

publication date

1 April 2002

1 reference

Annals of Allergy, Asthma & Immunology

16 June 2017

published in

1 reference

16 June 2017

volume

88

1 reference

16 June 2017

issue

4 Suppl 1

1 reference

16 June 2017

page(s)

16-22

1 reference

Cysteinyl leukotrienes in asthma: old mediators up to new tricks

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Rhinosinusitis in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Screening for sinus disease in patients with asthma: a computed tomography-controlled comparison of A-mode ultrasonography and standard radiography

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Does allergic rhinitis predispose to sinusitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Nasal polyposis, eosinophil dominated inflammation, and allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Role of nasal allergy in chronic maxillary sinusitis--diagnostic value of nasal challenge with allergen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962024-8

7 January 2021

10.1016/S1081-1206(10)62024-8

Identifiers

DOI

1 reference

16 June 2017

1 reference